Evidence map›Paper›PMID 39660921›Full record

ReviewmBio2025

Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.

Benjamin S Goldberg, Margaret E Ackerman

Abstract readReview
In one paragraph

Review in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Benjamin S GoldbergThayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA.
Margaret E AckermanThayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA.ORCID 0000-0002-4253-3476

Funding

Structure-Function Analytics CoreP01AI162242 · NIAID · DUKE UNIVERSITY · PI TOMARAS, GEORGIA DORIS · 2021 to 2025
$22.2M
Transferred ImmunityU19AI145825 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PASETTI, MARCELA F · 2021 to 2025
$16.0M
Using monoclonal antibody Fc variants in strategies to eliminate HIV reservoirsR01AI129801 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HESSELL, ANN JONES · 2017 to 2021
$4.2M
Understanding and optimizing antibody-based interventions against neonatal HSV infectionR01AI176646 · NIAID · DARTMOUTH COLLEGE · PI Margaret E Ackerman, David A Leib · 2023 to 2026
$3.1M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) P01AI162242HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI129801HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI176646HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI145825NIAID NIH HHS P01 AI162242NIAID NIH HHS R01 AI129801NIAID NIH HHS R01 AI176646NIAID NIH HHS U19 AI145825
6 · The paper itself

Abstract

The biologic activities of antibody drugs are dictated by structure-function relationships-emerging from the kind, composition, and degree of interactions with a target antigen and with soluble and cellular antibody receptors of the innate immune system. These activities are canonically understood to be both modular: antigen recognition is driven by the heterodimeric antigen-binding fragment, and innate immune recruitment by the homodimeric constant/crystallizable fragment. The model that treats these domains with a high degree of independence has served the field well but is not without limitations. Here, we consider how new insights, particularly from structural studies, complicate the model of neat biophysical separation between these domains and shape our understanding of antibody effector functions. The emerging model endeavors to explain the phenotypic impact of both antibody intrinsic characteristics and extrinsic features-fitting them within a spatiotemporal paradigm that better accounts for observed antibody activities. In this review, we will use insights from recent models of classical complement complexes and T cell immune synapse formation to explore how structural differences in antibody-mediated immune synapses may relate to their functional diversity.

Indexed as

AntibodiesImmunological SynapsesAnimalsHumansImmunity, InnateT-LymphocytesAntibodiesantibodyeffector functionimmune synapsemechanism of action

Identifiers

PMID39660921
PMCPMC11708040

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.